The state of Texas currently has 51 active clinical trials seeking participants for Healthy research studies. These trials are conducted in various cities, including Houston, Dallas, San Antonio and Austin.
A Study of LY3437943 in Participants With Impaired and Normal Liver Function
Recruiting
The main purpose of this study is to measure how much of LY3437943 gets into the bloodstream and how long it takes the body to eliminate it in participants with mild, moderate and severe impaired liver function compared to healthy participants with normal liver function. The safety and tolerability of LY3437943 will also be evaluated. The study may last up to 9 weeks for each participant including the screening period.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
03/25/2024
Locations: American Research Corporation at Texas Liver Institute, San Antonio, Texas +1 locations
Conditions: Healthy, Hepatic Insufficiency
A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis
Recruiting
The main purpose of this study is to evaluate the safety and tolerability of LY3872386 in healthy participants and participants with atopic dermatitis. The safety of prednisone is also evaluated in healthy participants. Blood tests will be performed to investigate how the body processes the LY3872386 following single and multiple dosing in healthy participants and participants with atopic dermatitis. Blood tests will also be performed to investigate how the body processes the prednisone in healt... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/25/2024
Locations: Progressive Clinical Research, San Antonio, Texas
Conditions: Healthy, Atopic Dermatitis
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
Recruiting
The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased absorption of dietary oxalate, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will ingest fixed diets containing low and moderately high amounts of oxalate for 5 days at a time ingest a soluble form of oxalate and... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
03/25/2024
Locations: UTSW, Dallas, Texas
Conditions: Kidney Stone, Kidney Calculi, Urolithiasis, Urolithiasis, Calcium Oxalate, Nephrolithiasis, Nephrolithiasis, Calcium Oxalate, Oxalate Urolithiasis, Oxaluria, Healthy
A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study
Recruiting
To learn if an 8-week, phone-based texting intervention program will reduce sedentary (non-mobile) behavior.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/20/2024
Locations: M D Anderson Cancer Center, Houston, Texas
Conditions: Life Style, Healthy Lifestyle
Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations
Recruiting
Background: During the first few decades of life, the brain changes dramatically in shape and function. Sleep lets researchers measure these changes. Researchers want to create a database of sleep and neurodevelopmental data in a group of infants and children to learn more. Objective: To address a knowledge and data gap in the field of sleep and neurodevelopment in infants and children. Eligibility: Children ages 6 months to 76 months who may or may not be at risk for neurodevelopmental and... Read More
Gender:
All
Ages:
Between 6 months and 8 years
Trial Updated:
03/16/2024
Locations: Texas Children's Hospital, Houston, Texas
Conditions: Healthy Children, Children With Neurodevelopmental Disorders, Children With Neuropsychiatric Disorders, Children With Behavioral Syndromes
Exploring the Effects of Corticosteroids on the Human Hippocampus
Recruiting
Chronic corticosteroid (CS) exposure is associated with changes in memory and the hippocampus in both humans and in animal models. The hippocampus has a high concentration of glucocorticoid receptors (GCRs), and the pre-clinical literature demonstrates shortening of apical dendrites in the CA3 region of the hippocampus and decreased neurogenesis in the dentate gyrus (DG) following CS administration. In humans, both stress and CS exposure are associated with a decline in declarative memory perfor... Read More
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
03/14/2024
Locations: UT Southwestern Medical Center, Dallas, Texas
Conditions: Hydrocortisone, Depression, Healthy Volunteers
A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Recruiting
The main purpose of this study is to assess the safety and tolerability of a single dose of LY3938577 in healthy participants and participants with Type 2 Diabetes Mellitus (T2DM) (Part A) and multiple doses of LY3938577 in participants with T2DM (Part B). The study will last approximately 6 weeks for Part A and approximately 10 weeks for Part B respectively.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
03/14/2024
Locations: Labcorp CRU, Dallas, Texas +1 locations
Conditions: Healthy, Type 2 Diabetes Mellitus
The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive Health
Recruiting
The overall research objective of this proposal is to determine the acute and chronic impact of daily supplementation of a Good Health beverage on indices of physiological and neurocognitive health.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
03/12/2024
Locations: UT Arlington - Science and Engineering Innovation and Research Building, Arlington, Texas +1 locations
Conditions: Cardiovascular Diseases, Hypertension, Cognitive Decline, Diet, Healthy
Peanuts and Neurocognitive / Cardiovascular Health in Black Individuals
Recruiting
The overall research objective of this proposal is to determine the impact of increased daily peanut consumption on indices of neurocognitive and physiological health in BL individuals
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
03/12/2024
Locations: UT Arlington - Science and Engineering Innovation and Research Building, Arlington, Texas
Conditions: Cardiovascular Diseases, Hypertension, Cognitive Decline, Diet, Healthy
The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health
Recruiting
The primary objectives of this application are to 1) investigate the effect of increased daily consumption of the Keto5 XOGenius beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. And 2) to investigate the effect of daily consumption of the Keto5 XOGenius beverage on the following variables: waist circumference, body weight, and body mass index (BMI).
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
03/12/2024
Locations: UT Arlington - Science and Engineering Innovation and Research Building, Arlington, Texas
Conditions: Cardiovascular Diseases, Hypertension, Cognitive Decline, Diet, Healthy
A Trial Investigating Lu AF28996 in Healthy Adult Participants
Recruiting
The purpose of this study is to investigate repeated doses of Lu AF28996 in healthy participants and co-administered with two other compounds, and in a separate cohort following co-administration with antibiotics, to see how well the doses are tolerated and what the body does to the drug after administering it.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
03/06/2024
Locations: Covance Dallas CRU, Dallas, Texas
Conditions: Healthy Participants
A Study to Assess Mass Balance, Pharmacokinetics, Metabolism, and Excretion of Emraclidine in Healthy Adult Male Participants
Recruiting
The primary purpose of this study is to determine the mass balance, routes, and rates of elimination of total radioactivity and characterize the pharmacokinetics (PK) of emraclidine, metabolite CV-0000364, and total radioactivity in plasma and whole blood following a single oral dose of [14C]-emraclidine in healthy adult male participants.
Gender:
Male
Ages:
Between 18 years and 55 years
Trial Updated:
03/04/2024
Locations: Austin, Texas, Austin, Texas
Conditions: Healthy Participants